Immune-Reactive Overlay: The Complete Guide to Heightened Immune Activity & Histamine Spectrum

If your "trigger foods" list has grown from 3 items to 30 over the past few years; if you flush, itch, or break out in hives after meals; if leftover food affects you more than fresh; if aged cheese, fermented foods, wine, vinegar, and tomato sauce reliably cause symptoms that range from sneezing and runny nose to abdominal cramping and racing heart; if you have multiple "allergies" but allergy testing comes back negative; if you have been diagnosed with IBS but the dominant feature is reactivity rather than pain or motility — you may be living with an Immune-Reactive overlay. This overlay describes a gut where the immune system is in a heightened state of activation, where mast cells and other immune cells are degranulating in response to foods, environmental triggers, and stressors, and where histamine and other inflammatory mediators are produced or accumulated faster than the body can clear them.

The Immune-Reactive overlay encompasses a clinical spectrum: from mild non-IgE food sensitivities, through histamine intolerance (HIT), to mast cell activation syndrome (MCAS). At the milder end, patients react to a handful of specific foods and benefit from targeted elimination plus enzyme support. At the more severe end, MCAS produces systemic symptoms (flushing, hives, GI distress, cardiac, neurological) and requires specialty evaluation and multi-system management. The overlay is one of seven overlays in the GutIQ system and frequently coexists with Inflammatory/Leaky-Prone primary pattern, where intestinal barrier dysfunction permits antigen passage into the lamina propria and triggers immune activation.

This guide is the practical companion to the GutIQ pattern pages and walks through what the Immune-Reactive overlay is, how it is scored, the science of food sensitivities versus allergies versus intolerances, the histamine spectrum (HIT, DAO deficiency, MCAS), structured testing and workup, the food strategy including low-histamine and elimination-reintroduction approaches, supplement protocols (DAO enzyme, quercetin, vitamin C, mast-cell stabilizers), lifestyle interventions, severe-case strategies including when to refer to an immunologist or allergist, and an FAQ. By the end you will have a complete map for moving from "I react to everything" to "I have identified my real triggers and have a working management plan."

A note on terminology: this guide uses "immune-reactive" broadly. Within this category, three more-specific clinical entities deserve attention: (1) non-IgE food sensitivities — delayed immune-mediated reactions to specific foods, distinct from IgE allergies; (2) histamine intolerance (HIT) — an imbalance between histamine accumulation and clearance by DAO/HNMT enzymes, producing post-meal flushing, GI symptoms, headaches, and other features; (3) mast cell activation syndrome (MCAS) — a more severe primary immunological diagnosis requiring specialty evaluation. This guide addresses all three with appropriate caveats.

The Physiology: Immune Activation, Mast Cells & the Histamine Cascade

The gut as the largest immune organ

Approximately 70-80% of the body's immune cells reside in the gut-associated lymphoid tissue (GALT). This is by design — the gut is the single largest interface between the body and the outside world, with an epithelial surface area approaching 30 square meters and constant exposure to dietary antigens, microbial products, and environmental molecules. The immune system must constantly distinguish between threats and tolerable substrates, mounting controlled responses to pathogens while maintaining tolerance to food and commensals. In the Immune-Reactive overlay, this discrimination breaks down, and the immune system reacts to substrates it should tolerate.

Mast cells and degranulation

Mast cells are tissue-resident immune cells found at high density in the gut mucosa, skin, respiratory tract, and around blood vessels. When activated by IgE-bound allergens, complement, neuropeptides (substance P, CRH), or direct food triggers, mast cells "degranulate" — releasing histamine, tryptase, prostaglandins, leukotrienes, and dozens of other mediators. These mediators produce the visible features: flushing, itching, hives, GI cramping, diarrhea, headache, racing heart, anxiety, and (in severe MCAS) anaphylaxis-spectrum reactions.

The histamine spectrum

Histamine has multiple sources in the body: endogenous production by mast cells and basophils, dietary intake (fermented and aged foods), and bacterial production by gut microbiota (certain Lactobacilli, Enterobacter, and others produce histamine from histidine). Histamine clearance depends on two enzymes: diamine oxidase (DAO) in the gut, which breaks down dietary histamine, and histamine N-methyltransferase (HNMT) in tissues, which clears systemic histamine. When intake plus production exceeds clearance capacity, histamine accumulates and produces symptoms — this is "histamine intolerance" (HIT). HIT is essentially a load-balance disorder, not a true allergy.

DAO insufficiency

DAO is produced in the small intestinal mucosa. Genetic polymorphisms (AOC1 gene) explain some interindividual variation in DAO activity. Mucosal damage from infection, inflammation, NSAIDs, alcohol, or certain medications (metformin, certain antibiotics, antidepressants, antihypertensives) reduces DAO activity. SIBO can compete with the mucosa for histamine-binding substrates. The result: dietary histamine that should be neutralized at the intestinal interface instead enters circulation and produces symptoms.

Non-IgE food sensitivities

Distinct from IgE-mediated allergies (which produce rapid, often severe, often anaphylactic reactions and are detected on standard allergy testing), non-IgE food sensitivities involve other immune mechanisms: cell-mediated reactions, food-specific IgG (controversial in clinical utility), eosinophilic infiltration, and mast cell sensitization without IgE. These reactions are typically delayed (hours to days after ingestion) and produce GI and systemic symptoms without the rapid hypersensitivity features of true allergy. Standard skin-prick or specific-IgE testing will miss these — yet they are clinically real and respond to elimination-reintroduction.

Mast Cell Activation Syndrome (MCAS)

MCAS is a primary immunological diagnosis where mast cells are chronically over-active and degranulate inappropriately in response to many triggers. It can be primary (clonal mast cell disorder, including mastocytosis) or secondary (post-viral, post-Lyme, idiopathic). Symptoms are multi-system: flushing, urticaria, GI distress (cramping, diarrhea), cardiovascular (tachycardia, hypotension), neurological (brain fog, headache, dizziness), respiratory (rhinitis, wheeze). The 2019 consensus criteria require: episodic multi-system symptoms consistent with mast cell activation, objective evidence of mast cell degranulation (elevated tryptase during episode, urinary metabolites), and response to mast-cell-targeted therapy. MCAS is increasingly recognized but still under-diagnosed; specialty evaluation by allergist/immunologist is required for formal diagnosis.

The barrier connection

Intestinal barrier dysfunction (often called "leaky gut") permits antigen passage into the lamina propria, where it triggers immune activation. The Inflammatory/Leaky-Prone primary pattern reflects this barrier dysfunction. When barrier dysfunction is severe and immune activation is significant, the result is the Immune-Reactive overlay. Repairing the barrier (L-glutamine, zinc carnosine, omega-3, anti-inflammatory polyphenols) reduces the antigen load reaching the immune system and addresses one of the root drivers of immune reactivity.

How GutIQ Scores the Immune-Reactive Overlay

The GutIQ assessment includes questions specifically designed to identify the Immune-Reactive overlay independent of primary pattern scoring. The overlay is scored based on: frequency of food-reactive symptoms, breadth of trigger foods (a growing list versus a few stable items), histamine-spectrum features (flushing, hives, runny nose after eating, reactions to aged/fermented foods), systemic features (joint pain, brain fog, anxiety post-meal), reactions to environmental triggers (heat, sun, exercise, hormonal cycles, stress), and severity of reactions.

A score below 25 indicates Immune-Reactive overlay is not clinically relevant. A score of 25-50 indicates mild reactivity — typically benefits from elimination-reintroduction targeting suspected triggers, DAO enzyme with high-histamine meals, and barrier-supportive supplements. A score of 51-75 indicates moderate-to-severe HIT spectrum — warrants structured low-histamine diet trial, comprehensive supplement protocol, and consideration of allergist consultation. A score above 75 indicates probable MCAS or severe HIT — requires specialist consultation, full multi-system workup, and combined dietary, supplement, and pharmacological management.

The overlay scoring also flags specific phenotypes: pure histamine-spectrum (responds to low-histamine and DAO), broad food-sensitivity pattern (responds to elimination-reintroduction), or MCAS-spectrum (requires specialty evaluation). These guide the specific protocol selection.

Immune-Reactive Overlay Symptoms: The Full Picture

Histamine-spectrum and mast cell symptoms

• Flushing of face, chest, and neck — particularly after meals or alcohol
• Hives (urticaria), itching, or rash without clear allergy diagnosis
• Runny nose, sneezing, or sinus congestion after meals (especially aged cheese, wine, leftover food)
• Headache or migraine after specific foods
• Racing heart, palpitations, or sense of cardiovascular instability after meals
• Dizziness or low blood pressure episodes
• Anxiety or panic-spectrum feelings after meals (histamine can produce anxiety-like symptoms)
• Brain fog or cognitive slowing post-meal
• Itchy ears, throat, or palate

Gastrointestinal symptoms

• Bloating that varies widely with food choices (not consistent like SIBO)
• Cramping or pain after meals, particularly with high-histamine foods
• Diarrhea after specific foods (histamine-driven motility acceleration)
• Reflux that flares with leftover food, wine, vinegar, fermented foods
• Constipation that paradoxically alternates with diarrhea
• Generalized food intolerance with no clear pattern

Skin and mucosal symptoms

• Eczema, rosacea, urticaria, or dermatographism (skin writing — pressure produces hives)
• Mouth sores or canker sores correlated with specific foods
• Itchy eyes, eye redness, photophobia
• Lip swelling or tongue tingling

Trigger patterns

• Reactions to leftover food (histamine accumulates as protein-rich foods age)
• Reactions worsen with wine, beer, champagne, vinegar, fermented foods
• Reactions worsen with aged cheese, cured meats, smoked fish, anchovies
• Reactions worsen with tomato, spinach, eggplant, avocado (high-histamine plants)
• Symptoms flare with heat, sun, exercise, hormonal cycle, stress, alcohol
• Symptoms flare during seasonal allergy season (pollen-load overlap)
• Multiple "allergies" reported but standard allergy testing comes back negative or weakly positive

Red flag symptoms requiring urgent evaluation

• Anaphylaxis or near-anaphylaxis (throat closing, breathing difficulty, sudden severe hypotension)
• Recurrent significant cardiovascular events with reactions
• Unexplained recurrent loss of consciousness
• Mucosal hemorrhage or unusual bleeding

These require urgent allergy/immunology evaluation; do not self-manage.

How Immune-Reactive Overlay Combines With Primary Patterns

Inflammatory/Leaky-Prone primary + Immune-Reactive overlay

The most common combination. Barrier dysfunction permits antigen passage, which fuels immune activation, which further damages the barrier. The Inflammatory/Leaky-Prone protocol (L-glutamine, zinc carnosine, omega-3, curcumin, anti-inflammatory polyphenols) is the foundation; the Immune-Reactive protocol (DAO, quercetin, vitamin C, mast cell stabilization, elimination diet) adds the specific reactivity component. See the Inflammatory/Leaky-Prone Pattern guide.

Fermentation Sensitive primary + Immune-Reactive overlay

Common combination. SIBO can be associated with histamine production by gut microbes; treating SIBO often reduces histamine load. Low-FODMAP and low-histamine diets overlap but are not identical — many low-FODMAP foods are high-histamine (e.g., aged cheese is low-FODMAP but high-histamine; spinach is high-histamine but low-FODMAP). Personalization is essential.

Stress-Reactive primary + Immune-Reactive overlay

Stress (CRH release) is a major mast cell activator. The stress-immune connection is bidirectional and self-reinforcing. Vagal tone work and CBT are particularly important.

Visceral Sensitivity primary + Immune-Reactive overlay

Mast cell-nerve cross-talk in the gut mucosa amplifies visceral pain perception. Mast cell stabilization (cromolyn, quercetin) helps both the immune and pain components.

Slow Transit primary + Immune-Reactive overlay

Constipation prolongs colonic fermentation and may amplify histamine production. Methane-IMO is associated with both slow transit and immune reactivity in some patients.

Other primary patterns

Any primary pattern can have an Immune-Reactive overlay. The personalized GutIQ report addresses your specific combination.

Testing & Workup for Immune-Reactive Overlay

Tier 1: Rule out true allergy and structural disease

• Allergy panel with allergist: Skin prick or specific IgE testing for true food allergies and environmental allergens
• Celiac panel: TTG-IgA + total IgA, with EMA confirmation if positive
• Comprehensive metabolic panel, CBC with differential
• Calprotectin (stool): Rule out inflammatory bowel disease
• Endoscopy and colonoscopy if alarm features or chronic symptoms warrant

Tier 2: Histamine-spectrum testing

• DAO activity (serum): Quest, LabCorp, or specialty labs — measures DAO enzyme activity. Low values (less than 10 HDU/mL) suggest functional DAO insufficiency.
• Plasma histamine: Useful but very time-sensitive (histamine has very short half-life); often missed unless drawn during an active reaction
• 24-hour urinary methylhistamine: More reliable than plasma; reflects total histamine turnover
• Histamine DAO genetic panel (AOC1 SNP): Identifies genetic predisposition to lower DAO; available through 23andMe data interpretation and specialty labs

Tier 3: MCAS workup (with allergist/immunologist)

• Serum tryptase: Baseline and during reaction. The 2019 consensus criteria require a 20% + 2 ng/mL rise from baseline during an active reaction. Persistently elevated baseline tryptase (greater than 11 ng/mL) raises concern for mastocytosis.
• 24-hour urinary N-methylhistamine, 11β-PGF2α, and leukotriene E4: Mast cell metabolite panel; gold standard for MCAS biochemistry
• Chromogranin A: Adjunct marker
• Bone marrow biopsy: If mastocytosis suspected (very elevated baseline tryptase, KIT mutation testing)

Tier 4: Functional and supportive testing

• SIBO breath test: Histamine-producing bacteria may be elevated in SIBO
• Comprehensive stool microbiome: Identify histamine-producing organisms
• Genetic methylation panel: MTHFR, MTRR, and others may affect histamine clearance via HNMT pathway
• Mold/environmental exposure assessment: Mycotoxin urine testing if chronic exposure suspected (relevant for overlay with environmental-seasonal overlay)

The role of IgG food panels

Commercial IgG food panels (Cyrex, ALCAT, Everlywell, etc.) are widely marketed but remain controversial in clinical utility. IgG can reflect exposure rather than reactivity, and panels often produce extensive "positive" lists that lead to over-restrictive elimination. Many guidelines (AAAAI, ACAAI) recommend against routine IgG food testing. If used, treat results as hypotheses to test via elimination-reintroduction, not as definitive diagnoses. A structured 4-week elimination of one major food group followed by oral challenge is more reliable than any IgG panel.

Food Strategy for Immune-Reactive Overlay

The structured elimination-reintroduction approach

The gold standard for identifying food sensitivities is structured elimination followed by single-food reintroduction. The protocol:

• Elimination phase (3-4 weeks): Remove suspected trigger food groups simultaneously. Common starting elimination: gluten, dairy, eggs, soy, corn, processed foods, alcohol. Symptom improvement within 2-3 weeks indicates one or more removed foods is contributing.
• Reintroduction phase (one food per 3-day period): Reintroduce one food at full portion daily for 3 days. Track symptoms. If significant reaction, the food is a probable trigger; if no reaction, the food is tolerated. Wait 3-day washout before next food.
• Personalization phase: Maintain restriction of identified trigger foods; reintroduce tolerated foods to broadest sustainable diet.

Work with a registered dietitian for accountability and to ensure nutritional adequacy.

Low-histamine diet

For patients with strong histamine-spectrum features (post-meal flushing, reactions to leftover food, fermented food intolerance), a structured low-histamine trial is reasonable. The protocol:

• Strict phase (2-4 weeks): Eliminate high-histamine foods (see lists below). Eat only fresh-cooked meals; minimize leftovers.
• Reintroduction phase: Gradually reintroduce moderate-histamine foods. Identify your specific threshold.
• Personalization: Avoid the most-triggering foods; tolerate the rest at appropriate doses.

High-histamine foods to limit during strict phase

• Aged and fermented: aged cheese (cheddar, parmesan, blue cheese), wine, beer, champagne, kombucha, sauerkraut, kimchi, yogurt (some), soy sauce, fish sauce, vinegar (most), miso, tempeh
• Cured and smoked: salami, prosciutto, smoked fish, anchovies, sardines, mackerel, tuna (canned)
• Leftover proteins: any cooked meat, fish, or poultry held more than 24-48 hours (histamine rises with aging)
• High-histamine plants: tomato, spinach, eggplant, avocado, citrus (especially in excess), pineapple
• Histamine liberators (foods that trigger release even without histamine content): egg whites, shellfish (some), strawberries, chocolate, alcohol
• Other: dried fruits, nuts (some — walnuts, cashews especially), processed snacks, MSG

Low-histamine foods generally well-tolerated

• Fresh proteins: chicken, turkey, lamb (cooked and eaten same day or frozen immediately), fresh fish (frozen at sea, cooked the day of thawing), eggs (yolk; some tolerate egg white)
• Grains: rice, quinoa, oats, sourdough wheat bread (if gluten-tolerated)
• Vegetables: cucumber, zucchini, carrots, broccoli, cauliflower, bell peppers (red and green), leafy greens (except spinach), green beans, asparagus
• Fruits: apple, pear, blueberry, watermelon, mango (some), peach, grape (in moderation)
• Fats: olive oil, coconut oil, butter (fresh), ghee
• Other: fresh herbs (basil, parsley, cilantro), salt, herbal teas (chamomile, peppermint — but mint is not for everyone), filtered water

Critical: food handling matters

Histamine accumulates as protein-rich foods age. The "leftover problem" is real:

• Buy fresh fish frozen-at-sea, not fresh-displayed (the latter has often been sitting for days)
• Cook meat and fish the day of thawing; freeze portions immediately after cooking if you cannot eat them within 24 hours
• Avoid restaurant leftovers and slow-cooker meals held warm for hours
• Avoid canned fish (high baseline histamine)

The autoimmune protocol (AIP) elimination

For patients with significant immune-reactive features, AIP (autoimmune protocol) is a more aggressive elimination removing all grains, legumes, nightshades, dairy, eggs, nuts, seeds, alcohol, coffee, and processed foods for 30-90 days followed by structured reintroduction. AIP is more restrictive than necessary for most patients but can be transformative for those with severe systemic reactivity. Work with a practitioner experienced with AIP if pursuing this path.

Supplement Protocol for Immune-Reactive Overlay

Tier 1: Foundation supplements

• DAO enzyme (Histamine Block, DAOzyme, Umbrellux DAO) 1-2 capsules 15 min before high-histamine meals: Provides exogenous DAO to break down dietary histamine. Most effective for HIT specifically.
• Quercetin 500 mg twice daily: Natural mast cell stabilizer; reduces histamine release. Take consistently for 4-8 weeks for full effect. Often combined with bromelain for absorption.
• Vitamin C 500-1,000 mg daily (split): Cofactor in DAO activity, antihistamine effect at higher doses, supports mast cell stabilization. Liposomal or buffered forms are gentler on the stomach.
• Stinging nettle (freeze-dried leaf) 300 mg twice daily: Natural antihistamine; particularly useful during seasonal allergy season.
• Zinc 15-30 mg daily for 8 weeks: Supports mucosal barrier and DAO synthesis. Limit to 8-week courses unless documented deficiency.

Tier 2: Barrier and inflammation support

• L-glutamine 5-10 g daily on empty stomach: Supports epithelial barrier; reduces antigen passage. Particularly important when Inflammatory/Leaky-Prone primary is also present.
• Omega-3 (high-EPA) 2,000-3,000 mg combined EPA+DHA daily: Anti-inflammatory, supports specialized pro-resolving mediators.
• Curcumin (Meriva or Theracurmin) 500 mg twice daily: Anti-inflammatory, supports immune modulation.
• Zinc carnosine 75 mg twice daily for 8 weeks: Mucosal protection and healing.
• Vitamin D 2,000-5,000 IU daily (titrated to serum 30-50 ng/mL): Supports regulatory T cell function and immune tolerance.

Tier 3: Advanced mast cell stabilization (with clinician)

• Cromolyn sodium (oral, prescription) 100-200 mg four times daily before meals: Mast cell stabilizer; standard MCAS treatment. Prescription required in most jurisdictions.
• H1 antihistamines (cetirizine, fexofenadine, loratadine) daily: Block histamine receptors; mainstay symptomatic management.
• H2 antihistamines (famotidine, cimetidine) twice daily: Block GI histamine receptors; complementary to H1.
• Leukotriene antagonists (montelukast) — for severe MCAS: Block leukotriene mediators.
• Ketotifen (compounded, prescription) — for refractory MCAS

Tier 4: Targeted strain probiotics

• Histamine-degrading strains: Bifidobacterium longum, Lactobacillus rhamnosus, L. salivarius, L. plantarum. Avoid histamine-producing strains like L. casei, L. bulgaricus, and certain L. helveticus products.
• Specific products: Seeking Health ProBiota HistaminX, Quintessential Probiotic Histamine-Free, MegaSporeBiotic (spore-based, typically histamine-friendly)

Lifestyle Interventions

Avoid mast-cell triggers beyond diet

Many MCAS and severe HIT patients have non-food triggers worth identifying and managing:

• Heat (hot showers, saunas) — can trigger flushing
• Cold exposure (some patients have paradoxical cold-induced mast cell activation)
• Exercise intensity (graded approach; avoid abrupt high intensity)
• Strong odors (perfumes, cleaning products, scented candles)
• Mold exposure in the home (HEPA filtration, mold remediation if present)
• Stress and emotional triggers
• Hormonal cycle phases (more triggers in luteal phase for many women)
• NSAID medications (can trigger flushing and reactions in some patients)
• Opioid medications (can trigger mast cell degranulation)

Stress and vagal tone

Stress is a potent mast cell trigger via CRH and substance P. Daily breathwork (10-15 minutes diaphragmatic breathing, box breathing, or paced breathing), gut-directed hypnotherapy (Nerva app), CBT, and meditation practices reduce baseline mast cell activation over weeks. Vagal tone work (cold face splash, humming, gargling, slow exhalation breathing) supports parasympathetic balance.

Sleep

Sleep deprivation increases mast cell mediator release. Prioritize 7-9 hours of consolidated sleep. Address sleep apnea if present (associated with mast cell activation).

Environment

• HEPA air filtration in bedroom (reduces inhaled mast cell triggers)
• Mold inspection and remediation if any home mold suspected
• Reduce fragranced products (perfume, candles, plug-ins, scented detergent)
• Filtered water (chlorine and contaminants can be mast cell triggers in sensitive patients)
• Address pet allergens if relevant

Structured 12-Week Protocol

Weeks 1-2: Foundation and assessment

• Begin food and symptom journal (track meals, environmental exposures, reactions)
• Begin Tier 1 supplements: quercetin 500 mg twice daily, vitamin C 1,000 mg split, DAO before high-histamine meals
• Order baseline labs: DAO activity, serum tryptase, 24-hour urinary methylhistamine if accessible
• Begin daily breathwork (10-15 minutes)
• Improve sleep hygiene

Weeks 3-6: Elimination phase

• Begin structured elimination diet (low-histamine for HIT-spectrum, or broader AIP-style for severe systemic reactivity)
• Continue all Tier 1 supplements
• Add Tier 2 barrier and inflammation support: L-glutamine, omega-3, zinc carnosine
• Consult with allergist/immunologist if MCAS suspected

Weeks 7-10: Reintroduction phase

• Begin single-food reintroductions (one food per 3-day period with 3-day washout)
• Track reactions carefully
• Continue all supplements
• Begin Tier 4 histamine-friendly probiotic if appropriate

Weeks 11-12: Personalization and optimization

• Construct personalized diet based on reintroduction findings
• Determine which supplements are essential ongoing versus optional
• Reassess symptoms with same scoring tool as week 1
• Plan ongoing maintenance protocol

Long-term maintenance

• Personalized diet (broadest tolerable, restricted only for true triggers)
• Maintenance supplement stack: quercetin, vitamin C, DAO as needed, omega-3, vitamin D
• Periodic stress and lifestyle review
• Annual follow-up with allergist/immunologist if MCAS established

Severe MCAS Intensive Protocol

If symptoms are severe, multi-system, and not adequately controlled with Tier 1-3 supplements alone, or if tryptase/methylhistamine testing confirms mast cell activation:

Specialist referral

Referral to an allergist/immunologist with MCAS expertise is essential. The Mast Cell Society and TMS (The Mastocytosis Society) maintain provider directories. Hematology-oncology referral if mastocytosis is suspected (very elevated tryptase, KIT mutation).

Layered pharmacological management (with specialist)

• H1 antihistamine (cetirizine 10-20 mg daily, fexofenadine 180 mg twice daily, or loratadine 10 mg daily)
• H2 antihistamine (famotidine 20-40 mg twice daily)
• Mast cell stabilizer: cromolyn sodium oral 100-200 mg four times daily before meals
• Leukotriene antagonist (montelukast 10 mg daily) — for respiratory and broad mast cell features
• Ketotifen (compounded) — for refractory cases
• Aspirin (low-dose, with PPI cover) — for some patients with prostaglandin-mediated features
• Omalizumab (anti-IgE biologic) — for severe MCAS with documented IgE component

Emergency action plan

Severe MCAS patients should have an emergency action plan, including:

• Epinephrine auto-injector (EpiPen) prescription, with clear instructions for use
• Knowledge of which triggers cause severe reactions
• Medical alert bracelet or wallet card
• Discussion with family/coworkers about emergency response
• Pre-medication protocols for known high-risk situations (medical procedures, contrast imaging, specific environmental exposures)

Address underlying contributors

• Treat SIBO if present (reduces microbial histamine production)
• Address mold exposure if present
• Optimize gut barrier with intensive Inflammatory/Leaky-Prone protocol
• Address chronic infections (Lyme, Bartonella, viral) if relevant
• Address stress, sleep, and lifestyle factors that drive baseline mast cell activation

Frequently Asked Questions

Get Your Personalized Immune-Reactive Plan

The Immune-Reactive overlay protocol in this guide is the evidence-based starting point. Your specific combination — primary pattern, overlay severity, histamine versus broader-sensitivity phenotype, MCAS likelihood, and overlapping conditions — shapes which interventions will work best for you. The GutIQ quiz takes the framework above and personalizes it.

Medical Disclaimer

This guide is for educational purposes and does not constitute medical advice. Immune reactions can range from benign sensitivities to life-threatening anaphylaxis. If you have had or may have had anaphylaxis, throat swelling, severe wheeze, sudden severe hypotension, or any potentially life-threatening reaction, seek immediate emergency care and arrange urgent allergy/immunology evaluation. Mast Cell Activation Syndrome diagnosis and treatment require specialist evaluation; do not self-diagnose or self-manage severe MCAS. Cromolyn sodium, prescription antihistamines, leukotriene antagonists, and other prescription medications referenced in this guide require clinical supervision. The supplements and doses assume normal kidney and liver function and no significant medication interactions. Pregnancy and lactation require separate guidance. Brand examples are illustrative; choose based on quality marks and third-party testing. Evidence summaries reflect literature current as of April 2026.